Correction to: Enhancing the HSV-1-mediated antitumor immune response by suppressing Bach1

Cell Mol Immunol. 2022 Jun;19(6):754. doi: 10.1038/s41423-022-00860-7.

Chaohu Pan^#^{1

2}, Qiaomei Cai^#³, Xiaorong Li³, Lili Li³, Liping Yang^{2

4}, Yu Chen^{1

2}, Junxiao Liu³, Wancheng Liu³, Meiling Gao³, Tianqi Sui^{1

2}, Xiaoyang Wang⁵, Huiming Fan³, Jiayin Ruan³, Yueyue Shi³, Saihua Chen⁶, Lucy S Cheng⁷, Jiayong Liu⁸, Heng Yang⁹, Genhong Cheng¹⁰

¹ Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College, 100005, Beijing, China.
² Suzhou Institute of Systems Medicine, Suzhou, 215123, Jiangsu, China.
³ Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, 100005, Beijing, China.
⁴ The Second Affiliated Hospital, Zhejiang University School of Medicine, 310009, Hangzhou, China.
⁵ Heze Vocational College, 274008, Heze, China.
⁶ Affiliated Tumor Hospital of Nantong University, 226000, Nantong, China.
⁷ Department of Dermatology, University of Pittsburgh Medical Center, 3708 Fifth Avenue, Suite 500.68, Pittsburgh, PA, 15213, USA.
⁸ Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Bone and Soft Tissue Tumor, Peking University Cancer Hospital & Institute, 52 Fucheng Rd, 100142, Beijing, China. liujiayong_doc@163.com.
⁹ Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, 100005, Beijing, China. yhmyt@hotmail.com.
¹⁰ Department of Molecular and Medical Pharmacology and California NanoSystems Institute, University of California, Los Angeles, Los Angeles, CA, 90095, USA. gcheng@mednet.ucla.edu.

^# Contributed equally.

No abstract available

Publication types